Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | CPB2 | Q96IY4 | 9/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GHSR | Q92847 | 1/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | NMT1 | P30419 | 2/20 | 0.38 |
| ▸ | NMT2 | O60551 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30193364 | 1.00 | FOLH1 (0.53) | FOLH1CPB2MEN1KMT2AGHSR | |
| SCHEMBL29364969 | 1.00 | FOLH1 (0.53) | FOLH1CPB2MEN1KMT2AGHSR | |
| SCHEMBL30193402 | 1.00 | FOLH1 (0.53) | FOLH1CPB2MEN1KMT2AGHSR | |
| SCHEMBL29413008 | 0.96 | FOLH1 (0.49) | FOLH1CPB2MEN1KMT2AGHSR | |
| SCHEMBL29630707 | 0.96 | FOLH1 (0.49) | FOLH1CPB2MEN1KMT2AGHSR | |
| SCHEMBL8729043 | 0.94 | CPB2 (0.46) | FOLH1CPB2MEN1KMT2AGHSR | |
| SCHEMBL29381549 | 0.94 | CPB2 (0.46) | FOLH1CPB2MEN1KMT2AGHSR | |
| Trifluoroacetic Acid SCHEMBL30641537 | 0.94 | FOLH1 (0.47) | FOLH1CPB2MEN1KMT2AGHSR | |
| Bromide SCHEMBL8990122 | 0.93 | CPB2 (0.45) | FOLH1CPB2MEN1KMT2AGHSR | |
| Bromide SCHEMBL8990118 | 0.93 | CPB2 (0.45) | FOLH1CPB2MEN1KMT2AGHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116098828-B | New use of tetrapeptide derivatives for preparing composition for skin repair and tightening | 深圳市维琪科技股份有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-118240006-A | Cyclic tetrapeptides and compositions and uses thereof | 深圳市维琪科技股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-116098828-A | New use of tetrapeptide derivatives for preparing composition for skin repair and tightening | 深圳市维琪科技股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| US-20220110852-A1 | Pigment Stabilizers | ZAVERI CHANDA (US) | 2022-04-14 | — | — | US | claimed |
| EP-4747264-A1 | MICELLAR BIOACTIVE COLLAGEN-STIMULATING LIPOPEPTIDE | University of Reading (GB) | 2026-05-27 | — | — | EP | disclosed |
| US-12622855-B1 | Hyperpigmentation treatment cream and serum | ProCell Therapies, LLC (US) | 2026-05-12 | — | — | US | disclosed |
| US-12622855-B1 | Hyperpigmentation treatment cream and serum | ProCell Therapies, LLC (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4420654-B1 | TETRAPEPTIDE DERIVATIVE, COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF | SHENZHEN WINKEY TECH CO LTD (CN) | 2026-02-18 | — | — | EP | disclosed |
| WO-2025037123-A1 | MICELLAR BIOACTIVE COLLAGEN-STIMULATING LIPOPEPTIDE | UNIVERSITY OF READING (GB) | 2025-02-20 | — | — | WO | disclosed |
| CN-116528825-B | Tetrapeptide derivative, composition and application thereof | 深圳市维琪科技股份有限公司 | 2024-11-01 | — | — | CN | disclosed |
| US-20240301000-A1 | TETRAPEPTIDE DERIVATIVE,COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF | SHENZHEN WINKEY TECHNOLOGY CO., LTD (CN) | 2024-09-12 | — | — | US | disclosed |
| EP-4420654-A1 | TETRAPEPTIDE DERIVATIVE, COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF | Shenzhen Winkey Technology Co., Ltd (CN) | 2024-08-28 | — | — | EP | disclosed |
| CN-117050145-A | Hyaluronic acid modifier of cosmetic peptide and application thereof | 杭州湃肽生化科技有限公司 | 2023-11-14 | — | — | CN | disclosed |
| CN-116528825-A | Tetrapeptide derivative, and cosmetic composition or medicinal composition and application thereof | 深圳市维琪科技股份有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-116098828-A | New use of tetrapeptide derivatives for preparing composition for skin repair and tightening | 深圳市维琪科技股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-116098828-A | New use of tetrapeptide derivatives for preparing composition for skin repair and tightening | 深圳市维琪科技股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| WO-2023077339-A1 | TETRAPEPTIDE DERIVATIVE, COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2023-05-11 | — | — | WO | disclosed |
| US-11596665-B2 | Skin lightening formulations | ZAVERI CHANDA (US) | 2023-03-07 | — | — | US | disclosed |
| EP-3988080-A1 | PIGMENT STABILIZERS | Zaveri, Chanda (US) | 2022-04-27 | — | — | EP | disclosed |
| US-20220110852-A1 | Pigment Stabilizers | ZAVERI CHANDA (US) | 2022-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622855-B1 | Hyperpigmentation treatment cream and serum | CUTA, TSG101, S100A11 | FOLH1 808/4885CPB2 689/4885MEN1 3667/4885 |
| US-20240301000-A1 | TETRAPEPTIDE DERIVATIVE,COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF | TYR, KYNU, MC1R | FOLH1 2603/4885CPB2 2011/4885MEN1 2574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.